Direkt zum Inhalt
Merck

Sural nerve sorbitol in patients with diabetic sensorimotor polyneuropathy.

Diabetes care (2004-04-28)
Vera Bril, Yoshiyuki Ono, Robert A Buchanan
ZUSAMMENFASSUNG

Nerve sorbitol levels have been measured in sural nerve biopsy samples from patients with diabetic sensorimotor polyneuropathy in several studies using different methods and measurement units. In this study, we compared the results of sorbitol assays to determine the required sensitivity of analytical methods for nerve sorbitol measurements. We performed a literature search using PaperChase for reports of nerve sorbitol in diabetic patients and selected those with nerve conduction studies to delineate the severity of nerve damage. In patients who had undergone a nerve conduction study, the standardized nerve sorbitol levels were 0.034-0.300 nmol/mg wet nerve. Our results showed the level of sensitivity required in laboratory methodology to perform this assay in the target population and aid in the planning of clinical research trials of aldose reductase inhibitor agents.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
D-Sorbit, ≥98% (GC)
Sigma-Aldrich
D-Sorbit, BioUltra, ≥99.0% (HPLC)
Sigma-Aldrich
D-Sorbit, 99% (GC)
Sigma-Aldrich
D-Sorbit, ≥98% (GC), Molecular Biology
Supelco
Sorbit, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Sorbit, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
D-Sorbit, ≥98% (GC), BioReagent, suitable for cell culture, suitable for plant cell culture
Sorbit, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Sorbit F -Lösung, 70 wt. % in H2O, Contains mainly D-sorbitol with lesser amounts of other hydrogenated oligosaccharides
Sigma-Aldrich
D-Sorbit, ≥98% (GC), BioXtra
Sigma-Aldrich
D-Sorbit, FCC, FG
Sigma-Aldrich
D-Sorbit, liquid, tested according to Ph. Eur.